2btr: Difference between revisions
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
[[Category: transferase]] | [[Category: transferase]] | ||
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:06:18 2007'' | ||
Revision as of 21:59, 12 November 2007
|
STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
OverviewOverview
N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active, (IC50=808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By, exploiting crystal structures of several complexes between CDK2 and, inhibitors and applying structure-based drug design (SBDD), we rapidly, discovered a very potent and selective CDK2 inhibitor, 4-[(5-isopropyl-1,3-thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50=20 nM). The syntheses, structure-based analog design, kinases, inhibition data and X-ray crystallographic structures of CDK2/inhibitor, complexes are reported.
About this StructureAbout this Structure
2BTR is a Single protein structure of sequence from Homo sapiens with U73 as ligand. Active as Transferred entry: 2.7.11.1, with EC number 2.7.1.37 Structure known Active Site: AC1. Full crystallographic information is available from OCA.
ReferenceReference
Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors., Vulpetti A, Casale E, Roletto F, Amici R, Villa M, Pevarello P, J Mol Graph Model. 2006 Mar;24(5):341-8. Epub 2005 Nov 2. PMID:16260160
Page seeded by OCA on Mon Nov 12 21:06:18 2007